Chen M, Yu F, Zhang Y, Zhao M H
Renal Division and Institute of Nephrology, Peking University First Hospital, Beijing, PR China.
Postgrad Med J. 2005 Nov;81(961):723-7. doi: 10.1136/pgmj.2005.034215.
Antineutrophil cytoplasmic autoantibodies (ANCA) are serological markers of ANCA associated systemic vasculitides (AASV), which is one of the most common multisystem autoimmune diseases. Features of Chinese patients with AASV have not been fully investigated.
To analyse the clinical and pathological characteristics of Chinese patients with AASV.
426 Chinese patients with AASV diagnosed in the past eight years were retrospectively studied and their clinical and pathological data were analysed.
Of the 426 patients, 87 (20.4%) were Wegener's granulomatosis, 337 (79.1%) were microscopic polyangiitis and two (0.5%) were Churg-Strauss syndrome. Only 201 of 426 (47.2%) patients were diagnosed within three months. Clinically, the patients had multisystem involvement. Altogether 371 of 426 (87.1%) had kidney involvement and 260 of 426 (61.0%) had lung involvement. The prevalences of renal involvement and fatigue were significantly higher in patients with MPO-ANCA than that in patients with PR3-ANCA; the prevalences of ophthalmic, nasal involvement, rash, and arthragia were significantly higher in patients with PR3-ANCA than those in patients with MPO-ANCA. The one and five year death rates were 13.1% and 22.4%, respectively. The percentage of patients progressing to end stage renal disease at one and five years was 15.9% and 27.1%, respectively.
AASV is not a rare autoimmune disease in Chinese people. Kidney and lung were the most vulnerable organs. For patients with multiorgan damage, an ANCA test should be performed to make an early diagnosis and to start treatment in time.
抗中性粒细胞胞浆抗体(ANCA)是ANCA相关性系统性血管炎(AASV)的血清学标志物,AASV是最常见的多系统自身免疫性疾病之一。中国AASV患者的特征尚未得到充分研究。
分析中国AASV患者的临床和病理特征。
回顾性研究过去八年中诊断的426例中国AASV患者,并分析其临床和病理数据。
426例患者中,87例(20.4%)为韦格纳肉芽肿,337例(79.1%)为显微镜下多血管炎,2例(0.5%)为变应性肉芽肿性血管炎。426例患者中仅201例(47.2%)在三个月内确诊。临床上,患者有多系统受累。426例患者中共有371例(87.1%)有肾脏受累,426例患者中有260例(61.0%)有肺部受累。MPO-ANCA患者的肾脏受累和疲劳发生率显著高于PR3-ANCA患者;PR3-ANCA患者的眼部、鼻部受累、皮疹和关节痛发生率显著高于MPO-ANCA患者。1年和5年死亡率分别为13.1%和22.4%。1年和5年进展至终末期肾病的患者百分比分别为15.9%和27.1%。
AASV在中国人群中并非罕见的自身免疫性疾病。肾脏和肺是最易受累的器官。对于有多器官损害的患者,应进行ANCA检测以尽早诊断并及时开始治疗。